Skip to main content

Accolade, Inc. (ACCD)

NASDAQ: ACCD · IEX Real-Time Price · USD
12.01
-0.84 (-6.54%)
At close: Dec 29, 2023, 4:00 PM
11.95
-0.06 (-0.50%)
After-hours: Dec 29, 2023, 7:44 PM EST

Accolade Revenue

Accolade had revenue of $380.06M in the twelve months ending August 31, 2023, with 8.47% growth year-over-year. Revenue in the quarter ending August 31, 2023 was $96.86M with 10.52% year-over-year growth. In the fiscal year ending February 28, 2023, Accolade had annual revenue of $363.14M with 17.13% growth.

Revenue (ttm)
$380.06M
Revenue Growth
+8.47%
P/S Ratio
2.41
Revenue / Employee
$160,363
Employees
2,370
Market Cap
915.55M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Feb 28, 2023363.14M53.12M
17.13%
Feb 28, 2022310.02M139.66M
81.98%
Feb 28, 2021170.36M37.85M
28.57%
Feb 28, 2020132.51M37.70M
39.76%
Feb 28, 201994.81M17.98M
23.41%
Feb 28, 201876.83M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
MultiPlan 958.48M
Fulgent Genetics 286.41M
Simulations Plus 59.58M
CureVac 45.62M
4D Molecular Therapeutics 21.99M
Revenue Rankings

ACCD News

More News